Cite
HARVARD Citation
Hynes, S. et al. (n.d.). Evaluation of the likelihood of a selective CHK1 inhibitor (LY2603618) to inhibit CYP2D6 with desipramine as a probe substrate in cancer patients. Biopharmaceutics & drug disposition. pp. 49-63. [Online].